These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7678080)

  • 1. Evaluating prethrombotic state in lung cancer using molecular markers.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
    Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
    BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study.
    Kitayama H; Kondo T; Sugiyama J; Kurimoto K; Nishino Y; Hirayama M; Tsuji Y
    BMC Cancer; 2017 May; 17(1):351. PubMed ID: 28525975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents.
    Sato Y; Kaji M; Metoki N; Yoshida H; Satoh K
    J Neurol Sci; 2003 Aug; 212(1-2):55-8. PubMed ID: 12809999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII as a Novel Biomarker for Diagnosis, Prognosis, and Therapy Prediction in Human Cancer and Other Disorders.
    Khalilian S; Mohajer Z; Ghafouri-Fard S
    Avicenna J Med Biotechnol; 2024; 16(2):68-80. PubMed ID: 38618505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response.
    Setiawan L; Setiabudy R; Kresno SB; Sutandyo N; Syahruddin E; Jovianti F; Nadliroh S; Mubarika S; Setiabudy R; Siregar NC
    Cancer Biomark; 2024; 39(2):137-153. PubMed ID: 38073374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors and Prediction Models for Venous Thromboembolism in Ambulatory Patients with Lung Cancer.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; De Rosa S; Mortazavi R
    Healthcare (Basel); 2021 Jun; 9(6):. PubMed ID: 34205695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer.
    Rosell A; Aguilera K; Hisada Y; Schmedes C; Mackman N; Wallén H; Lundström S; Thålin C
    Sci Rep; 2021 Mar; 11(1):5074. PubMed ID: 33658563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.
    Celli BR; Anderson JA; Brook R; Calverley P; Cowans NJ; Crim C; Dixon I; Kim V; Martinez FJ; Morris A; Newby DE; Yates J; Vestbo J
    BMJ Open Respir Res; 2019; 6(1):e000431. PubMed ID: 31258919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of Basic-Hemostatic Markers in Lung Cancer Patients During Follow-Up Care After Radiotherapy Treatment.
    Wolny-Rokicka EI; Wydmański J; Tukiendorf A; Mróz P; Zembroń-Łacny A
    Med Sci Monit; 2018 Nov; 24():8577-8582. PubMed ID: 30479323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perioperative Venous Thromboembolism (VTE) Prophalaxis 
in Thoracic Cancer Patients: Chinese Experts Consensus].
    Li H; Jiang G;
    Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):739-752. PubMed ID: 30309425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery.
    Li H; Jiang G; Bölükbas S; Chen C; Chen H; Chen K; Chen J; Cui X; Fang W; Gao S; Gilbert S; Fu J; Fu X; Hida Y; Li S; Li X; Li Y; Li H; Li Y; Liu D; Liu L; He J; He J; Marulli G; Oizumi H; de Perrot M; Petersen RH; Shargall Y; Sihoe A; Tan Q; Wang Q; Xu S; Yang M; Yang Y; Yu Z; Zhang L; Zhang X; Zhao H; Zhi X
    J Thorac Dis; 2018 May; 10(5):3039-3053. PubMed ID: 29997971
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma.
    Fan S; Guan Y; Zhao G; An G
    Thorac Cancer; 2018 Jan; 9(1):146-151. PubMed ID: 29131503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer.
    Liu X; Chen X; Yang J; Guo R
    Oncol Lett; 2017 Sep; 14(3):3787-3794. PubMed ID: 28927148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.
    Guo R; Yang J; Liu X; Wu J; Chen Y
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival.
    Tekeşin K; Bayrak S; Esatoğlu V; Özdemir E; Özel L; Melih Kara V
    Gastroenterol Res Pract; 2016; 2016():4295029. PubMed ID: 27651789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and lung cancer: a review.
    Vitale C; D'Amato M; Calabrò P; Stanziola AA; Mormile M; Molino A
    Multidiscip Respir Med; 2015; 10(1):28. PubMed ID: 26380084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of plasma D-dimer levels in patients with advanced non-small-cell lung cancer.
    Wang Y; Wang Z
    Onco Targets Ther; 2015; 8():805-8. PubMed ID: 25926741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
    Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
    BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.